Lupus

Lupus2019-01-29T15:53:37+00:00

Below is a sample of existing clinical evidence:

“Allogeneic UC MSCs (umbilical cord mesenchymal stem cells) were infused intravenously on days 0 and 7… no transplantation-related adverse events were observed. 32.5% patients achieved MCR (major clinical response), 27.5% patients achieved PCR (partial clinical response) during 12 months of follow up.”

– “Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study,” Wang et al, Arthritis Research & Therapy, 2014

Contact Us to Receive a Quote!

Get Started